Aptus Capital Advisors
CVS icon

Aptus Capital Advisors’s CVS Health CVS Stock Holding History

Aptus Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.04M Buy
70,487
+1,268
+2% +$124K 0.04% 342
2026
Q2 		$7.16M Buy
69,219
+3,777
+6% +$337K 0.05% 291
2026
Q1 		$4.7M Buy
65,442
+50,382
+335% +$3.88M 0.04% 350
2025
Q4 		$1.2M Buy
15,060
+246
+2% +$19.4K 0.01% 539
2025
Q3 		$1.12M Sell
14,814
-1,421
-9% -$97.4K 0.01% 539
2025
Q2 		$1.12M Buy
16,235
+3,813
+31% +$250K 0.01% 510
2025
Q1 		$842K Buy
12,422
+412
+3% +$24.7K 0.01% 538
2024
Q4 		$539K Sell
12,010
-68
-0.6% -$3.82K 0.01% 616
2024
Q3 		$759K Buy
12,078
+865
+8% +$50.5K 0.01% 461
2024
Q2 		$662K Buy
11,213
+19
+0.2% +$1.19K 0.01% 456
2024
Q1 		$893K Buy
11,194
+1,436
+15% +$110K 0.02% 412
2023
Q4 		$770K Sell
9,758
-555
-5% -$39.5K 0.02% 323
2023
Q3 		$720K Buy
10,313
+2,922
+40% +$207K 0.02% 334
2023
Q2 		$511K Sell
7,391
-61
-0.8% -$4.34K 0.01% 323
2023
Q1 		$554K Buy
7,452
+818
+12% +$68.6K 0.01% 312
2022
Q4 		$618K Buy
6,634
+120
+2% +$11.6K 0.02% 326
2022
Q3 		$621K Buy
6,514
+1,551
+31% +$154K 0.01% 303
2022
Q2 		$459K Sell
4,963
-1,353
-21% -$132K 0.01% 287
2022
Q1 		$640K Buy
6,316
+3,457
+121% +$363K 0.02% 281
2021
Q4 		$295K Buy
2,859
+348
+14% +$32.2K 0.01% 317
2021
Q3 		$213K Sell
2,511
-63
-2% -$5.28K 0.01% 346
2021
Q2 		$215K Buy
+2,574
New +$211K 0.01% 350
2019
Q2 		– Sell
-26,107
Closed -$1.41M – 339
2019
Q1 		$1.41M Buy
26,107
+3,401
+15% +$210K 0.24% 97
2018
Q4 		$1.49M Buy
+22,706
New +$1.69M 0.39% 38

Other funds holding CVS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Aptus Capital Advisors's CVS Position: Q3 2026 in Review

Aptus Capital Advisors increased its CVS Health (CVS) stake by 1.8% in Q3 2026, buying an estimated $124K and bringing the position to 70,487 shares worth $6.04M. The position accounts for 0.04% of the portfolio, ranked #342.

Aptus Capital Advisors first reported a position in CVS in Q4 2018 and has held it in 24 quarters since. The position peaked at $7.16M in Q2 2026. 1,724 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Aptus Capital Advisors held 70,487 shares of CVS Health worth $6.04M as of Q3 2026.
  • Aptus Capital Advisors bought 1,268 CVS Health shares in Q3 2026, an estimated $124K.
  • CVS Health made up 0.04% of Aptus Capital Advisors's portfolio in Q3 2026, its #342 holding.
  • Aptus Capital Advisors first reported a position in CVS Health in Q4 2018 and has held it in 24 quarters since.
  • Aptus Capital Advisors's CVS Health position peaked at $7.16M in Q2 2026.
  • 1,724 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Aptus Capital Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.